Histone deacetylase inhibitors modulate K(ATP) subunit transcription in HL-1 cardiomyocytes through effects on cholesterol homeostasis

Histone deacetylase inhibitors (HDIs) are under investigation for the treatment of a number of human health problems. HDIs have proven therapeutic value in refractory cases of cutaneous T-cell lymphoma. Electrocardiographic ST segment morphological changes associated with HDIs were observed during d...

Descripción completa

Detalles Bibliográficos
Autores principales: Fatima, Naheed, Cohen, Devin C., Sukumar, Gauthaman, Sissung, Tristan M., Schooley, James F., Haigney, Mark C., Claycomb, William C., Cox, Rachel T., Dalgard, Clifton L., Bates, Susan E., Flagg, Thomas P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534802/
https://www.ncbi.nlm.nih.gov/pubmed/26321954
http://dx.doi.org/10.3389/fphar.2015.00168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4534802/
https://www.ncbi.nlm.nih.gov/pubmed/26321954
http://dx.doi.org/10.3389/fphar.2015.00168

Ejemplares similares